234 related articles for article (PubMed ID: 16634696)
1. Is there a need for a new generation of vaccines against pertussis?
Storsaeter J; Wolter J
Expert Opin Emerg Drugs; 2006 May; 11(2):195-205. PubMed ID: 16634696
[TBL] [Abstract][Full Text] [Related]
2. Bordetella pertussis from functional genomics to intranasal vaccination.
Locht C; Antoine R; Raze D; Mielcarek N; Hot D; Lemoine Y; Mascart F
Int J Med Microbiol; 2004 Apr; 293(7-8):583-8. PubMed ID: 15149035
[TBL] [Abstract][Full Text] [Related]
3. Re-emergence of pertussis: what are the solutions?
Libster R; Edwards KM
Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
[TBL] [Abstract][Full Text] [Related]
4. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergström J; Ljungman M; Törner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C
PLoS One; 2014; 9(1):e83449. PubMed ID: 24421886
[TBL] [Abstract][Full Text] [Related]
5. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
6. Human Immune Responses to Pertussis Vaccines.
Ausiello CM; Mascart F; Corbière V; Fedele G
Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460
[TBL] [Abstract][Full Text] [Related]
7. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
8. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
Cornford-Nairns R; Daggard G; Mukkur T
J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
[TBL] [Abstract][Full Text] [Related]
9. Pertussis vaccines: state-of-the-art and future trends.
Tefon BE; Özcengiz E; Özcengiz G
Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
[TBL] [Abstract][Full Text] [Related]
10. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
[TBL] [Abstract][Full Text] [Related]
11. Rationale for pertussis booster vaccination throughout life in Europe.
Zepp F; Heininger U; Mertsola J; Bernatowska E; Guiso N; Roord J; Tozzi AE; Van Damme P
Lancet Infect Dis; 2011 Jul; 11(7):557-70. PubMed ID: 21600850
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
Kurova N; Timofeeva EV; Guiso N; Macina D
Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
[TBL] [Abstract][Full Text] [Related]
13. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
[TBL] [Abstract][Full Text] [Related]
14. Pertussis control: time for something new?
Clark TA; Messonnier NE; Hadler SC
Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
Bouchez V; Guiso N
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
[TBL] [Abstract][Full Text] [Related]
16. The persistence of pertussis and developments in vaccination strategies.
Heininger U
Lancet Respir Med; 2015 Sep; 3(9):668-670. PubMed ID: 26380881
[No Abstract] [Full Text] [Related]
17. Pertussis: acellular, whole-cell, new vaccines, what to choose?
Locht C
Expert Rev Vaccines; 2016 Jun; 15(6):671-3. PubMed ID: 26938372
[No Abstract] [Full Text] [Related]
18. Whooping cough, twenty years from acellular vaccines introduction.
Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
[TBL] [Abstract][Full Text] [Related]
19. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.
Mielcarek N; Debrie AS; Mahieux S; Locht C
Clin Vaccine Immunol; 2010 Mar; 17(3):317-24. PubMed ID: 20107007
[TBL] [Abstract][Full Text] [Related]
20. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
